Back

Characterisation of hypertrophic response and the effect of a GATA4-targeting compound on the phenotype of hypertrophic cardiomyopathy patient-derived hiPSC-cardiomyocytes

26 August 2023 (09:15 - 09:50)
Organised by: Logo
Congress Presentation Part of: IPS and other cell models Drugs, Drug Targets ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Ms Saana Annika Pohjavaara

University of Helsinki, Helsinki (Finland)

6 More presentations in this session

Presentation thumbnail
Sarcomere disassembly and transfection efficiency in proliferating human iPSC-derived cardiomyocytes
Mr Q. Yuan (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
HIF-1 regulates common bidirectional gene expression changes during hypoxia and iron deficiency in human induced pluripotent stem cell derived cardiomyocytes
Doctor C. Papadopoulou (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Massive expansion of functional human iPSC-derived cardiomyocytes by concomitant glycogen synthase kinase-3 beta inhibition and removal of cell-cell contact
Assistant Professor J. Buikema (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Scalable and stable human pluripotent stem cell-derived microvascular-like endothelial cells for cardiac regeneration and disease modelling applications.
Doctor Q. Majid (Helsinki, FI)
Abstract Slides Video
Presentation thumbnail
Development of a human in vitro model of bone marrow vascular niche on a chip to study CD34+ hematopoietic stem/progenitor cells function in diabetes
Doctor M. Campanile (Milan, IT)
Abstract Slides Video

Access the full session

Session thumbnail
IPS and other cell models

The Event

Event poster

ESC Congress 2023

26 August 2023 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Understanding the aetiology of HCM and pathways for intervention
thumbnail
Congress Presentation
Myosin inhibitors in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Myosin inhibitors as novel drugs for hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources